Pharmaceutical and diagnostic company Roche said Sunday that its coronavirus antibody test was granted emergency authorization by the Food and Drug Administration, and that it can churn out over 100 million of the kits by the end of this year, as governments search for ways to safely reopen communities and let people go back to work.
